Combined Administration of Begacestat and Donepezil: A Multiple-Dose Study in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 01 Apr 2011
At a glance
- Drugs Begacestat; Donepezil
- Indications Alzheimer's disease; Attention deficit and disruptive behaviour disorders; Dementia; Vascular dementia
- Focus Pharmacodynamics
- Sponsors Wyeth
- 19 Jul 2010 Pfizer added as trial sponsor as reported by ClinicalTrials.gov.
- 03 Apr 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 24 Aug 2009 New trial record